Dynavax Technologies
DVAX
$11.20
Share price
1.08%
Change (1 day)
-5.56%
Change (1 year)
Categories
P/S ratio for Dynavax Technologies (DVAX)
P/S ratio as of May 2023 (TTM): 2.20
According to Dynavax Technologies 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.195. At the end of 2023 the company had a P/S ratio of 1.92.
P/S ratio history for Dynavax Technologies from 2004 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.92 | 2.23% |
| 2022 | 1.88 | -51.09% |
| 2021 | 3.84 | -63.54% |
| 2020 | 10.5 | -22.67% |
| 2019 | 13.6 | -80.59% |
| 2018 | 70.2 | -97.98% |
| 2017 | > 1000 | 25045.31% |
| 2016 | 13.8 | -93.99% |
| 2015 | 229 | 470.45% |
| 2014 | 40.2 | -12.18% |
| 2013 | 45.8 | -14.64% |
| 2012 | 53.6 | 175.33% |
| 2011 | 19.5 | 26.1% |
| 2010 | 15.4 | 708.02% |
| 2009 | 1.91 | 111.82% |
| 2008 | 0.9025 | -93.74% |
| 2007 | 14.4 | -80.83% |
| 2006 | 75.2 | 1006.01% |
| 2005 | 6.80 | -46.81% |
| 2004 | 12.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 2.28 | 4.04% | 🇺🇸 USA |
 Amgen AMGN | 4.43 | 101.63% | 🇺🇸 USA |
 Biogen BIIB | 4.28 | 94.90% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.56 | 61.99% | 🇺🇸 USA |
 Merck MRK | 4.87 | 121.88% | 🇺🇸 USA |
 AstraZeneca AZN | 5.13 | 133.60% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2.02 | -7.93% | 🇬🇧 UK |
 Agenus
AGEN | 5.16 | 135.11% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 0.5688 | -74.08% | 🇮🇱 Israel |